Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Clinical trial NCT06716814 · RECRUITING

Trial details

NCT number: NCT06716814
Sponsor: Swedish Orphan Biovitrum
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilia A (Moderate or Severe)

Start date: 2025-03-06
Primary completion: 2027-03-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.